Clinical trial
Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia
NCT00565175
Study timeline
Study start (unknown)2008-01-01Date precision: month
Registry last updated2012-03-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
famotidineDRUG · verified · RxNorm: famotidine
Sponsors & collaborators
Jesper Ekelundlead sponsor
Finland: Lilly saatio foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00565175 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.